Biotechnology Portfolio Biotechnology Fund Last Dividend Paid
| FBIOX Fund | USD 19.49 0.18 0.93% |
Biotechnology Portfolio Biotechnology fundamentals help investors to digest information that contributes to Biotechnology Portfolio's financial success or failures. It also enables traders to predict the movement of Biotechnology Mutual Fund. The fundamental analysis module provides a way to measure Biotechnology Portfolio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotechnology Portfolio mutual fund.
Biotechnology |
Biotechnology Portfolio Biotechnology Mutual Fund Last Dividend Paid Analysis
Biotechnology Portfolio's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Current Biotechnology Portfolio Last Dividend Paid | 0.03 |
Most of Biotechnology Portfolio's fundamental indicators, such as Last Dividend Paid, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotechnology Portfolio Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Biotechnology Portfolio Biotechnology has a Last Dividend Paid of 0.03. This is 50.0% lower than that of the Fidelity Investments family and significantly higher than that of the Health category. The last dividend paid for all United States funds is 95.38% higher than that of the company.
Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Fund Asset Allocation for Biotechnology Portfolio
The fund consists of 96.05% investments in stocks, with the rest of investments allocated between different money market instruments and various exotic instruments.Asset allocation divides Biotechnology Portfolio's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Biotechnology Fundamentals
| Price To Earning | 29.21 X | ||||
| Price To Book | 3.43 X | ||||
| Price To Sales | 7.71 X | ||||
| Annual Yield | 0.01 % | ||||
| Year To Date Return | 0.85 % | ||||
| One Year Return | 6.51 % | ||||
| Three Year Return | 6.77 % | ||||
| Five Year Return | 4.67 % | ||||
| Ten Year Return | 19.82 % | ||||
| Net Asset | 4.78 B | ||||
| Last Dividend Paid | 0.03 | ||||
| Cash Position Weight | 0.41 % | ||||
| Equity Positions Weight | 96.05 % |
About Biotechnology Portfolio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotechnology Portfolio Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotechnology Portfolio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotechnology Portfolio Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Portfolio financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Portfolio security.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |